why mpns transform to aml
Published 8 years ago • 2.2K plays • Length 23:38Download video MP4
Download video MP3
Similar videos
-
23:39
why mpn transforms to aml
-
20:58
mpn transformation to mds and aml: risk factors, therapy, and outcomes
-
20:12
mpn transformation to mds and aml: risk factors, therapy and outcomes
-
29:02
current understanding of a genetic/epigenetic basis of classic mpns
-
0:50
introduction to myeloproliferative neoplasms (mpns)
-
25:48
the who updated diagnostic criteria for mpn
-
21:33
therapeutic insights in clonal evolution of mpn to accelerated or blastic phase
-
23:08
clonal evolution of mpn to accelerated or blastic phase: therapeutic insights
-
21:46
current understanding of a genetic/epigenetic basis of classic mpns
-
22:18
use of molecular genetic testing in mds and mpn
-
17:53
biology of aml developing from mds vs. de novo aml, and new targets for therapy
-
27:35
expert perspectives: mpn and mds
-
18:36
diagnostic challenges in mpn
-
1:59
driver mutations implicated in mpns
-
19:23
role of microenvironment in mpn
-
24:30
key insights: mpn and mds
-
2:35
what you should know about progression in mpns